Randomized Clinical Trial of Tele-Surveillance and Remote Symptom Monitoring Compared to Standard Surveillance for HPV-Associated Oropharynx Cancer with No Evidence of Disease on Post-Treatment Imaging
The incidence of Human Papilloma Virus (HPV) associated oropharyngeal cancer has risen rapidly over the past two decades with excellent prognosis and high rates of locoregional control. Post-treatment PET/CT for oropharyngeal cancer has a very high negative predictive value. Despite the improved outcomes for HPV-associated oropharyngeal cancer and the predictive value of post-treatment PET/CT, national guidelines for post-treatment surveillance of oropharyngeal cancer do not distinguish according to HPV status.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: K. Zakeri, D. Gelblum, L. Chen, A. Kriplani, W. Wong, Z. Zhang, A. Lopez, R.J. Wong, J.R. Cracchiolo, E. Sherman, N.Y. Lee Tags: 130 Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Clinical Trials | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Physics | Radiology